公司资料

Evaxion Biotech 股价、新闻与催化剂

股票代码:: EVAX
交易所:: NASDAQ
行业:: Biopharma
所在地:: Denmark

股票表现

3.22 USD (+6.27%)

收盘价

最后更新: 2026年9月17日

31.3M USD

市值

股价为何变动

截至 2026年9月17日，EVAX 上涨 6.27%，收于 $3.22。当前新闻监测窗口内未发现新的同公司新闻。

公司概览

业务概览

Evaxion Biotech is a biotechnology company focused on AI-enabled vaccine and immunotherapy discovery. Its platform aims to combine computational methods with immune science to create new therapies.

所在地与行业分类

Headquartered in Denmark and listed on NASDAQ as an ADR, Evaxion has a global AI-biotech profile.

商业模式特征

The company depends on platform adoption, clinical validation, and the ability to convert AI-assisted discovery into pipeline value.

生物医药行业定位

Evaxion is a hybrid AI-biotech name whose valuation depends on both platform credibility and drug progress.

未来催化剂

Evaxion’s catalysts are AI-designed vaccine programs and any clinical or partnership update that shows the platform can turn computational design into human value. The next step matters because the company still needs real proof.